In a significant development in the world of boxing, Dan Rafael has reported that the B sample from Ryan Garcia’s post-fight drug test following his bout with Devin Haney has tested positive for ostarine. This news confirms the initial findings, adding a layer of controversy to what was one of the most anticipated fights of the year.

Ostarine, known for its muscle-building properties, is banned under most sports anti-doping regulations. The confirmation of the B sample has profound implications for Garcia, who had been hoping for a negative result to clear his name after the initial positive test.

Ryan Garcia, visibly shaken by the news, responded swiftly, expressing his concern and disappointment. “This is the news I was dreading,” said Garcia, who has maintained his innocence throughout the process. “I’ve always prided myself on being a clean athlete and this situation has been extremely stressful.”

The boxing community has been abuzz with reactions, as this development could potentially derail Garcia’s promising career. The positive test may lead to sanctions, including a possible suspension, which would significantly impact his future fights and marketability.

The situation also casts a shadow over the outcome of the fight against Haney, with fans and commentators questioning the legitimacy of the performance. As the sport’s regulatory bodies deliberate on the next steps, the boxing world watches closely, awaiting a resolution that will likely have lasting repercussions for the athletes involved.

In the meantime, Garcia’s team has stated that they are reviewing all potential causes for the positive test, including dietary supplements and other external factors. They have pledged full cooperation with the sporting authorities to resolve the matter transparently and fairly.

As the investigation continues, the focus remains on ensuring the integrity of the sport and the fair treatment of all its athletes.